Insulin detemir versus insulin suspension isophane in pregnant type 1 diabetics also receiving mealtime insulin aspart

Trial Profile

Insulin detemir versus insulin suspension isophane in pregnant type 1 diabetics also receiving mealtime insulin aspart

Completed
Phase of Trial: Phase III

Latest Information Update: 08 Dec 2011

At a glance

  • Drugs Insulin aspart; Insulin detemir; Insulin suspension isophane
  • Indications Diabetes in pregnancy; Pregnancy; Type 1 diabetes mellitus
  • Focus Adverse reactions; Registrational; Therapeutic Use
  • Most Recent Events

    • 08 Dec 2011 Results, including the primary endpoint, presented at the 21st World Diabetes Congress.
    • 08 Dec 2011 Results presented at the 21st World Diabetes Congress.
    • 16 Sep 2011 Primary endpoint results presented at the 47th Annual Meeting of the European Association for the Study of Diabetes.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top